ABCC2, ABCC3, and ABCB1, but not CYP3A, Protect against Trabectedin-Mediated Hepatotoxicity.
about
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.A perspective on efflux transport proteins in the liverIrreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report.Drug-induced liver injury in Oncology.
P2860
ABCC2, ABCC3, and ABCB1, but not CYP3A, Protect against Trabectedin-Mediated Hepatotoxicity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@ast
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@en
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@nl
type
label
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@ast
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@en
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@nl
prefLabel
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@ast
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@en
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@nl
P2093
P1476
ABCC2, ABCC3, and ABCB1, but n ...... tedin-Mediated Hepatotoxicity.
@en
P2093
Alfred H Schinkel
Cornelia M M van der Kruijssen
Els Wagenaar
Hilde Rosing
Jos H Beijnen
Rhandy M Eman
Robert A B van Waterschoot
P304
P356
10.1158/1078-0432.CCR-09-2127
P407
P577
2009-12-01T00:00:00Z